Providers, payers, and pharmaceutical manufacturers consequently must consider and incorporate shared decision-making opportunities and mechanisms when developing therapeutic pathways, differentiated treatment options, and reimbursement strategies.
The issues of access and available trained personnel are more complex in a world that has gone through a pandemic. “We’re seeing practitioners who are truly burned out,” says Chi. “COVID really drove everyone to the mat. It caused a large transition in specialty and PCP levels—people who were thinking about retiring are saying, ‘I’m done.’ ”
IV dislodgements happen on a daily basis, so common that everyone in the hospital environment is aware of them. Whether it’s a caregiver tripping over tubing or a patient rolling over in their sleep, these incidents are understandable. But because they’re so universal, IV dislodgements cost the U.S. healthcare system as much as $2 billion annually.
The rapid shift toward telehealth accelerated the adoption of remote patient monitoring and played a significant role in making at-home care a reality. This new care delivery model helped to reduce the spread of COVID-19 among the most vulnerable and allowed providers to deliver the full continuum of care for patients with acute and chronic illnesses.
Four in 10 hospitals have struggled to appropriately discharge patients due to staffing shortages. Moreover, 86% of hospitals say COVID-19 has made it harder to secure placement for discharged patients. With the lack of postacute care staffing, health systems are under pressure to extend the length of hospital stays—making the cost of care dramatically more expensive.
VBC should be a familiar concept these days, as CMS is pushing to have 90%–100% of reimbursement under VBC by 2030. That’s driving commercial relationships, employer/employee relationships, contracting, and more.
Change does not happen overnight; it takes time, strategy, and concerted effort. Take the U.S. commercial aviation industry, for instance. Over the past 20 years, the sector has decreased its overall fatality rates by 95%. This was achieved with the support of the Federal Aviation Administration, which worked with the industry to form a number of programs that monitor for and ensure compliance, like the Commercial Aviation Safety Team.
Liquid biopsies are not new; they have been used for years to detect tumor material in bodily fluids. As cells die, fragments of DNA are shed into a person’s blood. Liquid biopsies can detect this circulating DNA in the earliest stages of the disease, well before a tumor has begun growing.
The pandemic has rendered many established healthcare processes and workflows inefficient. To fix the inefficiencies rapidly, many providers have had to speed up their digital transformation efforts by as much as 74%. The changes have powered a meaningful shift in the role of analytics in healthcare.
According to a study by the National Center for Health Workforce Analysis that looked at the supply and demand projections of nurses, some states will experience a shortage of registered nurses and licensed practical/vocational nurses by 2030, and a report by the Association of American Medical Colleges projected a shortage of 139,000 physicians by 2033.